S. Rivest

Immunology · 2002–2009

A researcher in the Science corpus: 5 papers; trusts 7 researchers and is trusted by 12 researchers here, as inferred from the citation graph.

Subfields

Whom S. Rivest trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Qiao Zhou
  2. A. Mildner
  3. T. Wyss‐Coray
  4. S. Lehnardt
  5. Minh N. H. Nguyen
  6. A. Nimmerjahn
  7. U. Hanisch
  8. David J. Anderson
  9. Arthur Liesz

Who trusts S. Rivest overall

  1. Hugo D. Critchley
  2. Wei-Wei Chen
  3. Neil A. Harrison
  4. Xia Zhang
  5. George M. Slavich
  6. Rafael Franco
  7. Wenjuan Huang
  8. T. Wyss‐Coray

Papers from S. Rivest's perspective

Ordered by how strongly the researchers S. Rivest trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo (Science)
  2. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. (Neuron)
  3. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway (Proceedings of the National Academy of Sciences of the United States of America)
  4. Innate immunity: the missing link in neuroprotection and neurodegeneration? (Nature Reviews Neuroscience)
  5. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions (Nature Neuroscience)
  6. Interleukin 1 in the brain: biology, pathology and therapeutic target. (Trends in Neurosciences)
  7. Experimental autoimmune encephalomyelitis repressed by microglial paralysis (Nature Medicine)
  8. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. (Proceedings of the National Academy of Sciences of the United States of America)
  9. Toll-like receptors: critical proteins linking innate and acquired immunity (Nature Immunology)
  10. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. (Journal of the American Medical Association (JAMA))

Their papers